Innogenetics, an international diagnostics company that develops and markets diagnostic products to improve therapy management and patient health, announced the Italian launch of its LUMIPULSE® G1200, a fully automated chemiluminescent enzyme immunoassay (CLEIA) system, at the 1° Congresso della Medicina di Laboratorio (SIMel/SIBioC) in Parma, Italy on November 16.